The Fleming Fund's Phase I Report is now available.
The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.
We support low- and middle-income countries to generate, share and use data to improve antimicrobial use and encourage investment in AMR.
Programme Update
Celebrating a new milestone in the UK-Pakistan partnership to tackle AMR and strengthen health systems
Date: 27/06/2022
Inauguration of upgraded national laboratories, supported by the Fleming Fund, UK Health Security Agency and DAI.
News
African genomics project receives additional funding to map AMR transmission patterns across continent
Date: 05/07/2022
The Fleming Fund has awarded an AMR surveillance project, ‘SEQAFRICA’, with an additional £2.4 million. SEQAFRICA uses the innov…
How does the Fleming Fund’s approach to One Health reflect good practice? How can One Health be evaluated? These are questions bei…
Our independent evaluator, [Itad](https://www.itad.com/project/fleming-fund-independent-evaluation-supplier/), is evaluating whether the…
The Fleming Fund is working with Uganda’s health care system to break down the barriers to disease surveillance by strengthening laborato…
21
Active Country Grants
155
Countries have supplied data on use of antimicrobial medicines in animals to OIE database
65
National Action Plans developed with Fleming Fund support
11
Active Regional Grants